Glioblastoma Proto-Oncogene Sec61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress

Total Page:16

File Type:pdf, Size:1020Kb

Glioblastoma Proto-Oncogene Sec61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress Published OnlineFirst November 17, 2009; DOI: 10.1158/0008-5472.CAN-09-2775 Molecular Biology, Pathobiology, and Genetics Glioblastoma Proto-oncogene SEC61γ Is Required for Tumor Cell Survival and Response to Endoplasmic Reticulum Stress Zheming Lu,1,3 Lei Zhou,4 Patrick Killela,1 Ahmed B. Rasheed,1 Chunhui Di,1 William E. Poe,1 Roger E. McLendon,1 Darell D. Bigner,1 Christopher Nicchitta,2 and Hai Yan1 1Department of Pathology, The Pediatric Brain Tumor Foundation Institute, and The Preston Robert Tisch Brain Tumor Center at Duke and 2Department of Cell Biology, Duke University Medical Center, Durham, North Carolina; 3Department of Etiology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, People's Republic of China; and 4Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida Abstract cells to apoptosis (7). These findings may be of particular relevance Glioblastoma multiforme is the most prevalent type of adult to glioblastoma multiforme, which, because they are highly prolifer- brain tumor and one of the deadliest tumors known to man- ative tumors, display substantial microheterogeneity in glucose and kind. The genetic understanding of glioblastoma multiforme oxygen delivery. Recent studies show that UPR genes are upregu- is, however, limited, and the molecular mechanisms that facil- lated in gliomas (8), suggesting that the genetic alteration of the itate glioblastoma multiforme cell survival and growth within ER-based, protein folding machinery, a prominent metabolic feature the tumor microenvironment are largely unknown. We applied of glioblastoma multiforme, confers a growth advantage. γ digital karyotyping and single nucleotide polymorphism ar- SEC61 is a member of the SEC61 translocon, a heterotrimeric α β γ rays to screen for copy-number changes in glioblastoma multi- protein channel comprising three subunits, SEC61 , , and (9). forme samples and found that the most frequently amplified The SEC61 complex forms a transmembrane pore for the translo- region is at chromosome 7p11.2. The high resolution of digital cation of nascent polypeptides into the ER lumen as well as the karyotyping and single nucleotide polymorphism arrays per- integration of transmembrane proteins into the ER bilayer (10). mits the precise delineation of amplicon boundaries and has In addition to the SEC61 complex, other proteins, such as ERj1, enabled identification of the minimal region of amplification SEC62, and SEC63, form the complete protein translocase involved at chromosome 7p11.2, which contains two genes, EGFR and in protein folding, modification, and translocation (11). Mutations SEC61γ. SEC61γ encodes a subunit of a heterotrimeric protein of ER-resident chaperones and the translocon have been identified channel located in the endoplasmic reticulum (ER). In addi- in cancer cells, indicating that ER proteins play an important role tion to its high frequency of gene amplification in glioblastoma in tumor pathogenesis. Of particular note, SEC62 and SEC63 are multiforme, SEC61γ is also remarkably overexpressed in 77% among the most frequently mutated and/or overexpressed genes of glioblastoma multiforme but not in lower-grade gliomas. in prostate, gastric, and colorectal cancers (12). γ The small interfering RNA–mediated knockdown of SEC61γ In the study described here, we found that SEC61 is not only expression in tumor cells led to growth suppression and apo- always coamplified with epidermal growth factor receptor (EGFR) ptosis. Furthermore, we showed that pharmacologic ER stress in 47% of glioblastoma multiforme but also overexpressed in 77% γ agents induce SEC61γ expression in glioblastoma multiforme of glioblastoma multiforme. In addition, SEC61 is required for tu- cells. Together, these results indicate that aberrant expression mor cell survival and response to ER stress reagents. of SEC61γ serves significant roles in glioblastoma multiforme cell survival likely via a mechanism that is involved in the cy- Materials and Methods toprotective ER stress–adaptive response to the tumor micro- environment. [Cancer Res 2009;69(23):9105–11] Tissue samples. Glioblastoma multiforme cell lines and frozen xeno- graft tumor samples were obtained from the tissue bank of the Preston Robert Tisch Brain Tumor Center at Duke. Acquisition of tissue specimens Introduction was approved by the Duke University Health System Institutional Review In tumors, hypoxia and nutrient deprivation of the solid-tumor Board. microenvironment inevitably subject tumor cells to ongoing cell Digital karyotyping. Digital karyotyping library construction and data stress (1–3). Under conditions of reduced oxygen and/or glucose analysis based on 25 glioblastoma multiforme samples were done as de- scribed previously (13, 14). Digital karyotyping protocols and software for availability, tumors exploit cellular stress response pathways to sup- 5 port tumor cell proliferation (4). The unfolded protein response extraction and analysis of genomic tags are available online. Analysis of copy-number variation. Single nucleotide polymorphism (UPR) is a set of cytoprotective signaling pathways that expands genotyping on genomic DNA from 32 glioblastoma multiforme samples, in- the endoplasmic reticulum (ER) processing capacity for misfolded cluding 7 pediatric glioblastoma multiforme, was done using the Illumina proteins and activates adaptive, antiapoptotic pathways (5, 6). How- HumanHap550 Genotyping BeadChip array. Raw data from the single nu- ever, if the survival mechanisms are exhausted, the UPR can commit cleotide polymorphism chips were collected and subjected to copy-number analysis using Nexus Copy Number Professional software (BioDiscovery). Quantitative real-time PCR analysis. Differences between glioblasto- Note: Supplementary data for this article are available at Cancer Research Online ma multiforme and normal brain cells in genomic DNA content of EGFR (http://cancerres.aacrjournals.org/). or SEC61γ were determined by quantitative real-time PCR (Q-PCR) as Requests for reprints: Hai Yan, Duke University Medical Center, Box 3156, Durham, NC 27710. Phone: 919-668-7850; Fax: 919-684-8756; E-mail: yan00002@mc. described previously (15). Relative gene expression levels of ATF4, Bip, duke.edu. ©2009 American Association for Cancer Research. doi:10.1158/0008-5472.CAN-09-2775 5 http://www.digitalkaryotyping.org www.aacrjournals.org 9105 Cancer Res 2009; 69: (23). December 1, 2009 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 2009 American Association for Cancer Research. Published OnlineFirst November 17, 2009; DOI: 10.1158/0008-5472.CAN-09-2775 Cancer Research CHOP, ATF6, Xbp1, EGFR, cyclin D1, and SEC61 α, β, and γ were measured tion, amplification of the EGFR is often associated with structural before and after treating the cells with 1 μg/mL of the ER stress inducer alterations in the gene, with the most common being variant III tunicamycin, and cDNA content was normalized to that of glyceraldehyde- (EGFR vIII), a 801-bp in-frame deletion of exons 2 to 7 of EGFR 3-phosphate dehydrogenase. present in 20% to 50% of glioblastoma multiforme with EGFR am- GeneChip analysis. Human U133A GeneChips (Affymetrix) were used plification (19). Here, the high resolution of genomic approaches for analysis of gene expression in 43 primary glioblastoma multiforme sam- ples and 4 normal brain tissues. The experimental protocols and data pro- revealed both focal amplification and intragenetic deletions of EGFR A cessing were described in a previous report (16). A hierarchical clustering (Fig. 1 ; Supplementary Fig. S1). tree and heat map were generated with dChip. For both cancer and normal It is of note that the genomic analyses revealed that SEC61γ,adja- tissues, an average difference value was normalized against the average dif- cent to EGFR, is always coamplified with EGFR in glioblastoma multi- ference of β-actin to obtain the internally normalized expression value. The forme. To verify the results obtained from genome-wide studies, we data were inputted into dChip, normalized against a normal tissue sample, performed Q-PCR analysis of EGFR and SEC61γ copy numbers on ge- and divided by the SD for each gene. nomic DNA extracted from an additional 43 tumors of primary glio- γ Small interfering RNA. SEC61 small interfering RNA (siRNA) se- blastoma multiforme patients (age >50 years). Of the 43 samples, 20 ′ ′ ′ quences 5 -GCCAAGUCGGCAGUUUGUAAAGGAC-3 and 5 -GUCCUUUA- samples (47%) displayed SEC61γ high copy-number gain (>4-fold) and CAAACUGCCGACUUGGC-3′ and a control scrambled GC siRNA were 17 samples (40%) displayed coincident EGFR high copy-number gain purchased from Invitrogen. B EGFR MTT assay. (>4-fold; Fig. 1 ). Interestingly, in no case was high copy-num- Cell viability assays were done as described previously (14). SEC61γ Briefly, assays were done consecutively from days 1 to 6 after siRNA trans- ber gain present without a corresponding high copy-number fection. A 10% solution of 5 mg/mL MTT diluted in PBS was added to the gain in the Q-PCR analysis (Fig. 1B;SupplementaryTableS1). cells and incubated for 30 min, and 600 μL isopropanol was then added to A previous population-based study indicated that the presence the plate and incubated for 5 min. Next, 200 μL of the mixed solution were of EGFR amplification does not affect survival of glioblastoma mul- transferred to a 96-well plate, and absorbance was measured at 570 nm. All tiforme patients at any age (20). We performed a survival
Recommended publications
  • Comprehensive Identification and Characterization of Somatic Copy Number Alterations in Triple‑Negative Breast Cancer
    INTERNATIONAL JOURNAL OF ONCOLOGY 56: 522-530, 2020 Comprehensive identification and characterization of somatic copy number alterations in triple‑negative breast cancer ZAIBING LI1,2*, XIAO ZHANG3*, CHENXIN HOU4, YUQING ZHOU4, JUNLI CHEN1, HAOYANG CAI5, YIFENG YE3, JINPING LIU3 and NING HUANG1 1Department of Pathophysiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041; 2Department of Pathophysiology, School of Basic Medical Science, Southwest Medical University, Luzhou, Sichuan 646000; 3Department of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan 611731; 4West China Medical School, Sichuan University, Chengdu, Sichuan 610041; 5Center of Growth, Metabolism and Aging, Key Laboratory of Bio‑Resources and Eco‑Environment, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, P.R. China Received January 30, 2019; Accepted August 30, 2019 DOI: 10.3892/ijo.2019.4950 Abstract. Triple-negative breast cancer (TNBC) accounts hierarchical clustering of tumors resulted in three main for ~15% of all breast cancer diagnoses each year. Patients subgroups that exhibited distinct CNA profiles, which with TNBC tend to have a higher risk for early relapse and may reveal the heterogeneity of molecular mechanisms in a worse prognosis. TNBC is characterized by extensive TNBC subgroups. These results will extend the molecular somatic copy number alterations (CNAs). However, the DNA understanding of TNBC and will facilitate the discovery of CNA profile of TNBC remains to be extensively investigated. therapeutic and diagnostic target candidates. The present study assessed the genomic profile of CNAs in 201 TNBC samples, aiming to identify recurrent CNAs that Introduction may drive the pathogenesis of TNBC.
    [Show full text]
  • Differentially Expressed on Collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All Rights Reserved. Symbol Entrez
    Differentially expressed on collagen Networks 1, 2, 10 © 2000-2009 Ingenuity Systems, Inc. All rights reserved. Symbol Entrez Gene Name Affymetrix Fold Change Location Family ALDH1A3 aldehyde dehydrogenase 1 family, member A3 203180_at -5.43125168 Cytoplasm enzyme 209772_s_ Plasma CD24 CD24 molecule at -4.32890229 Membrane other HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 204130_at -4.1099197 Cytoplasm enzyme Plasma AMOTL2 angiomotin like 2 203002_at -2.82872773 Membrane other transcription DLX2 distal-less homeobox 2 207147_at -2.74996362 Nucleus regulator 221215_s_ RIPK4 receptor-interacting serine-threonine kinase 4 at -2.56556472 Nucleus kinase PLK2 polo-like kinase 2 (Drosophila) 201939_at -2.47054478 Nucleus kinase ALDH3A1 aldehyde dehydrogenase 3 family, memberA1 205623_at -2.30532989 Cytoplasm enzyme TXNRD1 thioredoxin reductase 1 201266_at -2.27936909 Cytoplasm enzyme Extracellular CYR61 cysteine-rich, angiogenic inducer, 61 201289_at -2.09052668 Space other 214212_x_ FERMT2 fermitin family homolog 2 (Drosophila) at -1.87478183 Cytoplasm other Plasma RIT1 Ras-like without CAAX 1 209882_at -1.77586775 Membrane enzyme 210297_s_ Extracellular MSMB microseminoprotein, beta- at -1.72177723 Space other Extracellular PI3 peptidase inhibitor 3, skin-derived 203691_at -1.68135697 Space other ALDH3B1 aldehyde dehydrogenase 3 family, member B1 205640_at -1.67376791 Cytoplasm enzyme 202124_s_ Plasma TRAK2 trafficking protein, kinesin binding 2 at -1.6367793 Membrane transporter BMP and activin membrane-bound inhibitor Plasma BAMBI
    [Show full text]
  • MOLECULAR G EN ETICS of the January, HUMAN X
    MOLECULAR GENETICS OF THE HUMAN X CHROMOSOME BY DAVID ANDREW HARTLEY a thesis submitted for the degree of Doctor of Philosophy in the University of London January, 1984 Department of Biochemistry St. Mary's Hospital Medical School London W2 IPG 1 Abstract The comparison of frequency of recombination with chromosomal position has been possible only in Drosophila melanogaster but it is known that chiasma distribution in the human male (and many other species) is not random. A number of cloned DNA sequences have been isolated from a library enriched for X chromosome DNA by flow cytometry. The chromosomal loci complementary to these cloned sequences have been investigated by hybridization to somatic cell hybrid DNAs and by direct hybridization 1 in situ' to human metaphase spreads. In this way a cytological map of the X chromosome defined by DNA sequence markers has been constructed. Genetic distances complementary to the physical separations determined have been estimated by determining the segregation of DNA sequence variants at each locus in three generation p e d i g r e e s . The sequence variation is manifested as altered restriction fragment migration in agarose gels. It is intimated from these analyses that the pattern of recombination frequency along the human X chromosome mirrors the non-random chiasma distribution seen along male autosomes. This supports the chiasmatype theory and has implications on the availability of genetic components of the X chromosome to recombination. 2 To ray father in the hope of convincing him of life outside o f E.coli 3 ...scientists getting their kicks when deadly disease can do as it pleases results ain't hard to predict Gil Scott-Heron 4 Ack n ov; ledgements To my supervisor Bob Williamson for support.
    [Show full text]
  • Reproduction
    REPRODUCTIONRESEARCH Focus on Mammalian Embryogenomics Molecular and subcellular characterisation of oocytes screened for their developmental competence based on glucose-6-phosphate dehydrogenase activity Helmut Torner2, Nasser Ghanem, Christina Ambros2, Michael Ho¨lker, Wolfgang Tomek2, Chirawath Phatsara, Hannelore Alm2, Marc-Andre´ Sirard1, Wilhelm Kanitz2, Karl Schellander and Dawit Tesfaye Animal Breeding and Husbandry Group, Department of Animal Breeding and Husbandry, Institute of Animal Science, University of Bonn, Endenicher allee 15, 53115 Bonn, Germany, 1De´partement des Sciences Animales, Centre de Recherche en Biologie de la Reproduction, Universite´ Laval, Pav. Comtois, Laval, Sainte-Foy, Que´bec, G1K 7P4, Canada and 2Research Institute for the Biology of Farm Animals, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, Germany Correspondence should be addressed to D Tesfaye; Email: [email protected] Abstract Oocyte selection based on glucose-6-phosphate dehydrogenase (G6PDH) activity has been successfully used to differentiate between competent and incompetent bovine oocytes. However, the intrinsic molecular and subcellular characteristics of these oocytes have not yet been investigated. Here, we aim to identify molecular and functional markers associated with oocyte developmental potential when selected based on G6PDH activity. Immature compact cumulus–oocyte complexes were stained with brilliant cresyl blue (BCB) for 90 min. Based on K C their colouration, oocytes were divided into BCB (colourless cytoplasm, high G6PDH activity) and BCB (coloured cytoplasm, low G6PDH activity). The chromatin configuration of the nucleus and the mitochondrial activityof oocytes were determined by fluorescence labelling and photometric measurement. The abundance and phosphorylation pattern of protein kinases Akt and MAP were estimated by Western blot C K analysis.
    [Show full text]
  • 1471-2164-10-261.Pdf
    BMC Genomics BioMed Central Research article Open Access Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal Magdalena Chechlinska*1, Jan Konrad Siwicki1, Monika Gos2, Malgorzata Oczko-Wojciechowska3, Michal Jarzab4, Aleksandra Pfeifer3, Barbara Jarzab3 and Jan Steffen1 Address: 1Department of Immunology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland, 2Department of Cell Biology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland, 3Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland and 4Department of Tumor Biology and Clinical Oncology, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland Email: Magdalena Chechlinska* - [email protected]; Jan Konrad Siwicki - [email protected]; Monika Gos - [email protected]; Malgorzata Oczko-Wojciechowska - [email protected]; Michal Jarzab - [email protected]; Aleksandra Pfeifer - [email protected]; Barbara Jarzab - [email protected]; Jan Steffen - [email protected] * Corresponding author Published: 8 June 2009 Received: 20 February 2009 Accepted: 8 June 2009 BMC Genomics 2009, 10:261 doi:10.1186/1471-2164-10-261 This article is available from: http://www.biomedcentral.com/1471-2164/10/261 © 2009 Chechlinska et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The molecular mechanisms of cell cycle exit are poorly understood.
    [Show full text]
  • Combined Analysis of Genome-Wide Expression and Copy Number
    Fontanillo et al. BMC Genomics 2012, 13(Suppl 5):S5 http://www.biomedcentral.com/1471-2164/13/S5/S5 RESEARCH Open Access Combined analysis of genome-wide expression and copy number profiles to identify key altered genomic regions in cancer Celia Fontanillo1, Sara Aibar1, Jose Manuel Sanchez-Santos2, Javier De Las Rivas1* From X-meeting 2011 - International Conference on the Brazilian Association for Bioinformatics and Compu- tational Biology Florianópolis, Brazil. 12-15 October 2011 Abstract Background: Analysis of DNA copy number alterations and gene expression changes in human samples have been used to find potential target genes in complex diseases. Recent studies have combined these two types of data using different strategies, but focusing on finding gene-based relationships. However, it has been proposed that these data can be used to identify key genomic regions, which may enclose causal genes under the assumption that disease-associated gene expression changes are caused by genomic alterations. Results: Following this proposal, we undertake a new integrative analysis of genome-wide expression and copy number datasets. The analysis is based on the combined location of both types of signals along the genome. Our approach takes into account the genomic location in the copy number (CN) analysis and also in the gene expression (GE) analysis. To achieve this we apply a segmentation algorithm to both types of data using paired samples. Then, we perform a correlation analysis and a frequency analysis of the gene loci in the segmented CN regions and the segmented GE regions; selecting in both cases the statistically significant loci. In this way, we find CN alterations that show strong correspondence with GE changes.
    [Show full text]
  • Download Special Issue
    International Journal of Genomics Noncoding RNAs in Health and Disease Lead Guest Editor: Michele Purrello Guest Editors: Massimo Romani and Davide Barbagallo Noncoding RNAs in Health and Disease International Journal of Genomics Noncoding RNAs in Health and Disease Lead Guest Editor: Michele Purrello Guest Editors: Massimo Romani and Davide Barbagallo Copyright © 2018 Hindawi. All rights reserved. This is a special issue published in “International Journal of Genomics.” All articles are open access articles distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Andrea C. Belin, Sweden M. Hadzopoulou-Cladaras, Greece Ferenc Olasz, Hungary Jacques Camonis, France Sylvia Hagemann, Austria Elena Pasyukova, Russia Prabhakara V. Choudary, USA Henry Heng, USA Graziano Pesole, Italy Martine A. Collart, Switzerland Eivind Hovig, Norway Giulia Piaggio, Italy Monika Dmitrzak-Weglarz, Poland Hieronim Jakubowski, USA Mohamed Salem, USA Marco Gerdol, Italy B.-H. Jeong, Republic of Korea Wilfred van IJcken, Netherlands João Paulo Gomes, Portugal Atsushi Kurabayashi, Japan Brian Wigdahl, USA Soraya E. Gutierrez, Chile Giuliana Napolitano, Italy Jinfa Zhang, USA Contents Noncoding RNAs in Health and Disease Davide Barbagallo, Gaetano Vittone, Massimo Romani , and Michele Purrello Volume 2018, Article ID 9135073, 2 pages Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers Luka Bolha,
    [Show full text]
  • Candidate Genes for Alcohol Preference Identified by Expression
    Liang et al. Genome Biology 2010, 11:R11 http://genomebiology.com/2010/11/2/R11 RESEARCH Open Access Candidate genes for alcohol preference identified by expression profiling in alcohol-preferring and -nonpreferring reciprocal congenic rats Tiebing Liang1*, Mark W Kimpel2, Jeanette N McClintick3, Ashley R Skillman1, Kevin McCall4, Howard J Edenberg3, Lucinda G Carr1 Abstract Background: Selectively bred alcohol-preferring (P) and alcohol-nonpreferring (NP) rats differ greatly in alcohol preference, in part due to a highly significant quantitative trait locus (QTL) on chromosome 4. Alcohol consumption scores of reciprocal chromosome 4 congenic strains NP.P and P.NP correlated with the introgressed interval. The goal of this study was to identify candidate genes that may influence alcohol consumption by comparing gene expression in five brain regions of alcohol-naïve inbred alcohol-preferring and P.NP congenic rats: amygdala, nucleus accumbens, hippocampus, caudate putamen, and frontal cortex. Results: Within the QTL region, 104 cis-regulated probe sets were differentially expressed in more than one region, and an additional 53 were differentially expressed in a single region. Fewer trans-regulated probe sets were detected, and most differed in only one region. Analysis of the average expression values across the 5 brain regions yielded 141 differentially expressed cis-regulated probe sets and 206 trans-regulated probe sets. Comparing the present results from inbred alcohol-preferring vs. congenic P.NP rats to earlier results from the reciprocal congenic NP.P vs. inbred alcohol-nonpreferring rats demonstrated that 74 cis-regulated probe sets were differentially expressed in the same direction and with a consistent magnitude of difference in at least one brain region.
    [Show full text]
  • ECOP Shrna (H) Lentiviral Particles: Sc-89730-V
    SANTA CRUZ BIOTECHNOLOGY, INC. ECOP shRNA (h) Lentiviral Particles: sc-89730-V BACKGROUND APPLICATIONS ECOP (EGFR-coamplified and overexpressed protein), also known as VOPP1 ECOP shRNA (h) Lentiviral Particles is recommended for the inhibition of (vesicular, overexpressed in cancer, prosurvival protein 1) or GASP (glioblas- ECOP expression in human cells. toma-amplified secreted protein), is a 172 amino acid protein that is coam- plified with EGFR and overexpressed in multiple glioblastomas. Highly ex- SUPPORT REAGENTS pressed in ovary and thymus, ECOP is found at moderate levels in testis, Control shRNA Lentiviral Particles: sc-108080. Available as 200 µl frozen colon, small intestine, and spleen, and at low levels in liver, placenta and viral stock containing 1.0 x 106 infectious units of virus (IFU); contains an κ prostate. ECOP regulates NF B signaling and may have a role in resistance shRNA construct encoding a scrambled sequence that will not lead to the to apoptosis. The gene encoding ECOP maps to human chromosome 7, which specific degradation of any known cellular mRNA. houses over 1,000 genes, comprises nearly 5% of the human genome and has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, RT-PCR REAGENTS Citrullinemia and Shwachman-Diamond syndrome. Semi-quantitative RT-PCR may be performed to monitor ECOP gene expres- REFERENCES sion knockdown using RT-PCR Primer: ECOP (h)-PR: sc-89730-PR (20 µl). Annealing temperature for the primers should be 55-60° C and the extension 1. Tsipouras, P., Myers, J.C., Ramirez, F. and Prockop, D.J. 1983. Restriction temperature should be 68-72° C.
    [Show full text]
  • Identification and Analysis of Programmed Cell Death Genes in Drosophila Melanogaster and Human Cancer Using Biotnformatic Analysis of Gene Expression Data
    IDENTIFICATION AND ANALYSIS OF PROGRAMMED CELL DEATH GENES IN DROSOPHILA MELANOGASTER AND HUMAN CANCER USING BIOTNFORMATIC ANALYSIS OF GENE EXPRESSION DATA by ERBSf DAEL PLEASANCE B.Sc, The University of British Columbia, 2000 A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE STUDIES (Medical Genetics) THE UNIVERSITY OF BRITISH COLUMBIA December 2005 © Erin Dael Pleasance, 2005 Abstract Programmed cell death (PCD), or cell suicide, encompasses multiple pathways including apoptosis and autophagy and is essential for development, cellular homeostasis, and prevention of cancer cell growth. I describe here the development and use of bioinformatic methods to identify and analyze genes involved in PCD, both in the model organism Drosophila melanogaster and in human cancer, by analysis of large-scale gene expression data. An approach was developed to correctly identify genes from serial analysis of gene expression (SAGE) data, distinguish the set of genes not accessible to the SAGE method, and determine the optimal set of enzymes for Drosophila, C. elegans, and human SAGE library construction. In Drosophila metamorphosis the salivary gland undergoes autophagic PCD, whereby cellular components are engulfed and degraded by cytoplasmic vacuoles, with additional hallmarks of apoptosis. This is an excellent model in which to study the genes involved in PCD. Transcriptional profiling of this tissue by expressed sequence tags (ESTs) and serial analysis of gene expression (SAGE) identified many genes differentially regulated prior to cell death, including genes known to be death regulators, genes in related pathways, genes of no known function, and potentially novel unannotated genes.
    [Show full text]
  • High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray
    Published OnlineFirst May 12, 2009; DOI: 10.1158/1541-7786.MCR-08-0270 Published Online First on May 12, 2009 High-Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray Dong Yin,1 Seishi Ogawa,3 Norihiko Kawamata,1 Patrizia Tunici,2 Gaetano Finocchiaro,4 Marica Eoli,4 Christian Ruckert,6 Thien Huynh,1 Gentao Liu,2 Motohiro Kato,3 Masashi Sanada,3 Anna Jauch,5 Martin Dugas,6 Keith L. Black,2 and H. Phillip Koeffler1 1Division of Hematology/Oncology and 2Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California; 3Regeneration Medicine of Hematopoiesis, University of Tokyo, School of Medicine, Tokyo, Japan; 4National Neurological Institute “C Besta,” Milan, Italy; 5Institute of Human Genetics, University Hospital Heidelberg, Germany; and 6Department of Medical Informatics and Biomathematics, University of Munster, Munster, Germany Abstract growth factor receptor/platelet-derived growth factor receptor Glioblastoma multiforme (GBM) is an extremely malignant α. Deletion of chromosome 6q26-27 often occurred (16 of 55 brain tumor. To identify new genomic alterations in GBM, samples). The minimum common deleted region included genomic DNA of tumor tissue/explants from 55 individuals PARK2, PACRG, QKI,and PDE10A genes. Further reverse and 6 GBM cell lines were examined using single nucleotide transcription Q-PCR studies showed that PARK2 expression polymorphism DNA microarray (SNP-Chip). Further gene was decreased in another collection of GBMs at a expression analysis relied on an additional 56 GBM samples. frequency of 61% (34 of 56) of samples. The 1p36.23 region SNP-Chip results were validated using several techniques, was deleted in 35% (19 of 55) of samples.
    [Show full text]
  • Bcl2l10 Induces Metabolic Alterations in Ovarian Cancer Cells by Regulating the TCA Cycle Enzymes SDHD and IDH1
    ONCOLOGY REPORTS 45: 47, 2021 Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and IDH1 SU‑YEON LEE, JINIE KWON and KYUNG‑AH LEE Department of Biomedical Science, College of Life Science, CHA University, Seongnam, Gyeonggi 13488, Republic of Korea Received September 29, 2020; Accepted February 3, 2021 DOI: 10.3892/or.2021.7998 Abstract. Bcl2‑like‑10 (Bcl2l10) has both oncogenic and and the results indicated that Bcl2l10 may serve as a potential tumor suppressor functions depending on the type of cancer. therapeutic target in ovarian cancer. It has been previously demonstrated that the suppression of Bcl2l10 in ovarian cancer SKOV3 and A2780 cells causes Introduction cell cycle arrest and enhances cell proliferation, indicating that Bcl2l10 is a tumor suppressor gene in ovarian cancer Over the past years, cutting‑edge research and advanced cells. The aim of the present study was to identify possible screening, surgical and therapeutic technologies have contrib‑ downstream target genes and investigate the underlying uted to increasing the 5‑year relative survival rate for all types mechanisms of action of Bcl2l10 in ovarian cancer cells. of cancer from 68 to 86% from 2010 to 2016 in adolescents in RNA sequencing (RNA‑Seq) was performed to obtain a list of the United States (1). Despite these advances, the 5‑year overall differentially expressed genes (DEGs) in Bcl2l10‑suppressed survival rate for advanced ovarian cancer remains 29% after SKOV3 and A2780 cells. The RNA‑Seq data were validated diagnosis, as determined by statistics from 2008 to 2014 in by reverse transcription‑quantitative PCR (RT‑qPCR) and the USA (2).
    [Show full text]